{
  "retracted": false,
  "timestamp": 1358467200000,
  "updates": [
    {
      "timestamp": 1585403133860,
      "identifier": {
        "doi": "10.1007/s00280-012-2064-y"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s00280-012-1972-1"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023"
}
